| 
August
6, 2003 Issue 167
This
Week...
Our new product is a book by Catrine Tudor-Locke,
PhD, Author of Manpo-kei
(The Art & Science of Step Counting) and developer of
the First
Step Program, licensed by Diabetes in Control.
We will be featuring a new column by Catrine starting in
September.
Due to the large response from our notice of Richard
Bernstein’s new book, the publisher AOL/Time
Warner has agreed to let us post excerpts from each of the
24 chapters. Watch for it, beginning in September.
In February we selected Kelsey O., a 13
year old pump user, to try out the new UltraSmart meter.
She liked it so much she has written an article for us.
Read The World’s
Best Meter and find out what Kelsey has to
say.
The Mouth is Connected to the Heart and Brain, and Kidneys,
and….. Marilyn Porter, RD, CDE explains
the connection in Brushing
Up on Diabetes and Gum Disease. She describes
how to make a mouth model for you to use to teach your patients.
With only 1 day to go until AADE we want to remind you
that we will be in at Booth #1333, between
Roche, Aventis and Takeda. Please stop by to see our special
presentations. We are also having a STEP
Contest, Stop by our booth before Thursday
noon and pick up your free pedometer and then lets see who
gets the most steps for the next 3 day – 10 prizes
awarded to the top finishers. Click
here to find out more and what else is Happenings
This week’s overview:
Item#2:
Lifestyle Modification, Metformin Effective Prevention for
Type 2 Diabetes
Item:#4:
Chemical Process In The Brain Linked To Weight Gain And
Diabetes
Item #14:
Effect of Adding Exenatide (Synthetic Exendin-4) to Metformin
and/or Sulfonylurea Treatment in Patients With Type 2
Check out this weeks “Test Your Knowledge” question.
Click Here
Dave
Joffe, Editor-in-Chief, CDE, FACA
Consider
making Diabetes in Control Your home page.
NewsFlash:
FDA Soon To Approve New "Super Statin" Crestor
(rosuvastatin)
See Item#12
Due to the overwhelming response
to our information on Diachrome (chromium picolinate and biotin)
we have convinced the manufacturer “Nutrition 21”
to supply you, our medical professional readers, with samples
for personal or patient use.
Click
here to learn how to get them.

1. Depression Linked to HbA1c Levels in Patients With Type
1 But Not Type 2 Diabetes*
Click Here
2. Lifestyle Modification, Metformin Effective Prevention
for Type 2 Diabetes
Click Here
3. An Overly Tight Neck Tie Increases Risk of Glaucoma
Click Here
4. Chemical Process In The Brain Linked To Weight Gain And
Diabetes
Click Here
5. Blood Pressure Goals and Treatment Algorithms Improve
BP Control*
Click Here
6. Low-Dose Antihypertensive Combinations More Effective
Than Standard Doses Of Fewer Drugs*
Click Here
7. Serum Test Allows Early Intervention for Gestational
Diabetes
Click Here
8. Theophylline Improves Hypoglycemic Unawareness In Type
1's
Click Here
9 Low HDL Cholesterol Levels May Impair Endothelial Function
Click Here
10. Nurse-Led Clinics Help Diabetics Achieve Blood Pressure
and Lipid Goals*
Click Here
11. Fluconazole Increases Plasma Concentrations of Nateglinide
Click Here
12. FDA Soon To Approve New "Super Statin" Crestor
(rosuvastatin)
Click Here
13. U.S. Worried by Native Americans' High Diabetes Rate
Click Here
14. Effect of Adding Exenatide (Synthetic Exendin-4) to
Metformin and/or Sulfonylurea Treatment in Patients With
Type 2
Click Here
15. Results From Low–Glycemic Index Diets in the Management
of Diabetes
Click Here
Product
Update
A1cNow
is Now Over the Counter-No Prescription Needed!
Let
your Patients Check Their Own A1c Levels. It will motivate
to better control.
www.a1cnow.net
QUOTE OF THE WEEK
“No
person has ever been honored for what he received. Honor
has been the reward for what he gave.”
Calvin Coolidge
Prescription
Drug Plan Faces Tests
Insurers' Participation Uncertain, Experts
Say
Congress's dramatic pre-dawn votes
on Friday to add prescription drug benefits to Medicare
were a political milestone, authorizing the biggest
expansion of the program since its birth. But health
policy analysts say that, even if the House and the
Senate are able to resolve differences between their
bills, it is far from certain the plan would work.
The drug coverage envisioned by Congress and the White
House relies on two kinds of private insurance methods:
separate policies solely for drugs, something that
does not currently exist, and preferred-provider networks,
a health plan that is common among younger people
but includes few Medicare patients. Read
More...>
|
|